<p>HPV genotype distribution in the Ghana clinic and Kenya screening group.</p>

A-D) Number of HPV positive samples in the Ghana research group (A), clinician-collected group (B), self-collected non-screening group (C) and in the Kenya screening group (D), the number of HPV genotypes detected in one sample is indicated. E) Distribution of HPV genotypes in the Ghana research group. F) Distribution of HPV genotypes in the clinician-collected group. G) Distribution of HPV genotypes in the self-collected non-screening group. H) Distribution of HPV genotypes in the Kenya screening group. E-H) Prevalence is calculated using the number of HPV-positive participants as the denominator, the numbers above the bars indicate the absolute number of each genotype detected. Colours indicate prevalence of each genotype in a single genotype infection (black) or in a multiple genotype infection (green). High-risk genotypes are depicted in black; potential high-risk genotypes are depicted in grey.